Clinical Trial Update: Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN) [Phase 3]

View source ↗

Summary

Phase 3 trial PLAN is evaluating lidocaine infusions to prevent persistent pain after breast cancer surgery and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Post-mastectomy Pain Syndrome

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Post-mastectomy Pain Syndrome, Breast Cancer | Phase 3 | Status: RECRUITING